Trademark: 88977261
Word
XELLERA
Status Date
Tuesday, December 1, 2020
Registration Number
6211226
Registration Date
Tuesday, December 1, 2020
Filing Date
Monday, May 27, 2019
Published for Opposition
Tuesday, May 12, 2020
9 Bioreactor for cell culturing; Bioreactors for laboratory use; Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; Computer-controlled electronic apparatus for electrophysiological measurement and testing of cells
10 Apparatus for the regeneration of stem cells for medical purposes; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical apparatus and instruments for treating cardiovascular disease; Medical apparatus for introducing pharmaceutical preparations into the human body; Medical diagnostic apparatus for testing blood antigens and antibodies
40 Biomanufacturing for others, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process; Contract manufacturing in the field of biotechnology; Cryogenic preservation; Cryopreservation of human tissue; Custom manufacture of biopharmaceuticals by pharmaceutical compounders; Manufacture of pharmaceuticals to order and/or specification of others; Manufacturing services for others in the field of stem cells; Providing technical information in the field of pharmaceutical manufacturing
42 Biological research; Biomedical research services; Biotechnology research; Chemical research; Conducting clinical trials for others; Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Drug discovery services; Industrial research in the field of regenerative and reparative therapies; Medical laboratory services; Medical research; Pharmaceutical drug development services; Pharmaceutical research services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products for others; Research and development of vaccines and medicines; Scientific research; Scientific research and development; Scientific research in the field of gene therapy; Stem cell research services; Technology research in the field of regenerative and reparative therapies
44 Blood bank services; Health care services, namely, regenerative and reparative therapies; Human tissue bank services; Medical care; Medical services; Medical services in the field of regenerative and reparative therapies; Medical testing for diagnostic or treatment purposes in the field of regenerative and reparative therapies; Organ and tissue bank services; Stem cell therapy services
Color is not claimed as a feature of the mark.
The mark consists of the stylized design of the letter "X" and the stylized wording "ellera".
The wording "XELLERA" has no meaning in a foreign language.
Dec 8, 2021
Teas Change Of Correspondence Received
Dec 8, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 8, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 1, 2020
Registered-Principal Register
Oct 29, 2020
1(B) Basis Deleted; Proceed To Registration
Oct 8, 2020
Notice Of Allowance Cancelled
Oct 8, 2020
Teas Delete 1(B) Basis Received
Jul 7, 2020
Noa E-Mailed - Sou Required From Applicant
May 12, 2020
Official Gazette Publication Confirmation E-Mailed
May 12, 2020
Published For Opposition
Apr 22, 2020
Notification Of Notice Of Publication E-Mailed
Apr 9, 2020
Electronic Record Review Complete
Apr 3, 2020
On Hold - Electronic Record Review Required
Mar 26, 2020
Approved For Pub - Principal Register
Mar 26, 2020
Divisional Processing Complete
Feb 21, 2020
Divisional Request Received
Mar 24, 2020
Case Assigned To Intent To Use Paralegal
Feb 27, 2020
Assigned To Lie
Feb 21, 2020
Teas Response To Office Action Received
Feb 21, 2020
Teas Change Of Correspondence Received
Feb 21, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 21, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 21, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 21, 2020
Teas Change Of Owner Address Received
Feb 21, 2020
Teas Change Of Correspondence Received
Feb 21, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 21, 2020
Teas Change Of Owner Address Received
Feb 21, 2020
Teas Request To Divide Received
Dec 31, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 31, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 21, 2019
Notification Of Non-Final Action E-Mailed
Aug 21, 2019
Non-Final Action E-Mailed
Aug 21, 2019
Non-Final Action Written
Aug 15, 2019
Assigned To Examiner
Jun 11, 2019
New Application Office Supplied Data Entered In Tram
May 30, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
